secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001628280-26-027956
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal reclassifies two directors to balance board classes ahead of 2026 annual meeting
--------------------------------------------------------------------------------

- Julian C. Baker reclassified from Class III to Class I, term expiring at 2026 Annual Meeting.
- Daniel J. Brennan reclassified from Class II to Class I, effective April 22, 2026.
- Reclassification aims to achieve more equal apportionment among three board classes.
- Baker, Brennan, and James Daly nominated for re-election at June 17, 2026 meeting.
- No changes to committee assignments as a result of the reclassification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000162828026027956/0001628280-26-027956-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000162828026027956/mdgl-20260422.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-027956

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer